• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. PROXIMATE*RL LINEAR STAPLER; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. PROXIMATE*RL LINEAR STAPLER; STAPLE, IMPLANTABLE Back to Search Results
Model Number TX30B
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Failure to Anastomose (1028); Wound Dehiscence (1154); Blood Loss (2597)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Date of event: unknown.Batch # unknown.The lot/batch was not provided; therefore, the manufacturing records evaluation could not be performed.
 
Event or Problem Description
It was reported via journal article:title: end-to-end versus end-to-side stapled anastomoses after anterior resection for rectal cancer.Author(s): giuseppe brisinda, md, serafino vanella, md,1 federica cadeddu, md, ignazio massimo civello, md, francesco brandara, md, casimiro nigro, md, pasquale mazzeo, md, gaia marniga, md, and giorgio maria, md.Citation: j.Surg.Oncol.2009;99:75¿79.Doi: 1 0.1002/jso.21182.The aim of this study is the evaluation of early and late postoperative complications in t1¿t2 rectal cancer patients who underwent rectal resection with stapled end-to-end anastomosis or end-to-side anastomosis.Postoperative outcomes of the two procedures, clinicopathological features between patients with and without anastomotic leakage and between patients with and without anastomotic stenosis have been compared.Between jan 1998 and jan 2006, 77 patients with t1¿t2 rectal cancer underwent rectal resection with stapled anastomosis and were divided based on the technique of stapled anastomosis.In 37 patients (20 males and 17 females, mean age: 63.7±9.2 years) an end-to-end anastomosis was performed.In 40 cases (19 males and 21 females, mean age: 67.0±5.9 years) an end-to-side anastomosis was done.In the end-to-side group, the rectal stump was closed with a linear stapler (tx 30b, ethicon endosurgery, llc, cincinnati, oh) in 22 patients, a curved cutter stapler (cs 40g, ethicon endosurgery, llc) was used in 18 cases.Two patients of the end-to-side group experienced anastomotic leakage and were successfully treated with local washouts and antibiotics for 6 weeks.Further complication in this group included wound dehiscence (n=5), wound infection (n=8) and blood transfusion (n=?).We have noted that incomplete or poor bowel preparation, need for blood transfusions and location of anastomosis were statistically related to the development of the anastomotic leakage.End-to-side anastomosis resolves the great problem, particularly for the end-to-end anastomoses, related to the different diameter between the intestinal and the rectal stump.Regarding postoperative surgical complications, end-to-side anastomosis is a safe procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
*  00969
MDR Report Key9965126
Report Number3005075853-2020-02181
Device Sequence Number2857720
Product Code GDW
UDI-Device Identifier10705036003311
UDI-Public10705036003311
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K020779
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,literature
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberTX30B
Device Catalogue NumberTX30B
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/31/2020
Initial Report FDA Received Date04/15/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-